Emmanuel Antonarakis

Clark Endowed Professor, Division of Hematology, Oncology and Transplantation · University of Minnesota

Credentials: · · · ·

History

Mayo Clinic / University of Minnesota Prostate SPORE
National Cancer Institute · P50
PI · $2.2M · Mayo Clinic Rochester
2026–2031
The Aberrant Androgen Receptor Underlies Abiraterone/Enzalutamide Resistance
National Cancer Institute · R01
PI · $1.5M · Johns Hopkins University
2015–2020

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Principal investigator · Completed · Phase 2
Masonic Cancer Center, University of Minnesota
2019–2025
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2016–2021
Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2016–2019
Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
Principal investigator · Completed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2015–2017